Acumen Pharmaceuticals, Inc. (ABOS)
2.16
-0.01
(-0.46%)
USD |
NASDAQ |
Dec 24, 16:00
Acumen Pharmaceuticals Cash from Investing (Quarterly): 40.51M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Black Diamond Therapeutics, Inc. | 8.59M |
| Pulmonx Corp. | 8.711M |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
| Palatin Technologies, Inc. | 0.00 |
| Theriva Biologics, Inc. | -0.019M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -30.49M |
| Free Cash Flow | -123.74M |
| Free Cash Flow Per Share (Quarterly) | -0.5033 |
| Free Cash Flow to Equity (Quarterly) | -31.22M |
| Free Cash Flow to Firm (Quarterly) | -29.42M |
| Free Cash Flow Yield | -94.78% |